HomePCVX • NASDAQ
Vaxcyte Inc
add
$40.74
2.70%
After Hours:(1.99%)-0.81
$39.93
Closed: Oct 8, 7:45:12 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 226.22M | 47.87% |
Net income | -166.57M | -29.42% |
Net profit margin | — | — |
Earnings per share | -1.22 | -11.13% |
EBITDA | -223.34M | -47.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.66B | 14.37% |
Total assets | 3.31B | 58.36% |
Total liabilities | 234.03M | 131.40% |
Total equity | 3.07B | — |
Shares outstanding | 129.82M | — |
Price to book | 1.77 | — |
Return on assets | -16.92% | — |
Return on capital | -17.55% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -166.57M | -29.42% |
Cash from operations | -121.17M | 0.19% |
Cash from investing | 77.74M | 196.69% |
Cash from financing | 2.52M | -97.72% |
Net change in cash | -40.11M | 56.80% |
Free cash flow | -61.43M | 45.22% |
Previous close
$41.87
Day range
$40.73 - $42.86
Year range
$27.66 - $118.62
Market cap
5.29B USD
Avg Volume
1.91M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Headquarters
Website
Employees
414
